Because tumors defective in MMR exhibit high responsiveness to checkpoint blockade immunotherapy (42, 43), and because DNA damage response factors, particularly those involved in double-strand break repair, influence radiation and chemotherapy (45, 46), understanding the molecular mechanisms by which OTUB1 precisely regulates individual DNA damage response pathways will significantly benefit cancer treatments. This evidence concerns the gene OTUB1 and cancer.